Well, that didn’t last long. After yesterday’s tentatively positive start to the trading week, many investors may have hoped we had turned a corner on last week’s disastrous performance of the S&P/ASX 200 Index (ASX: JO). Alas, it was not to be.

The ASX 200 started in red territory this morning and only got worse over the session. By the time trading ended, the index had lost 0.88% of its value and had settled at 8,672.5 points.

This rather terrible Tuesday for Australian investors came after a similarly downbeat night on Wall Street overnight to kick off the American trading week.

The Dow Jones Industrial Average Index (DJX: .DJI) did start strong, but ended up recording a 0.29% loss.

The tech-heavy Nasdaq Composite Index (NASDAQ: .IXIC) fared even worse, dropping 0.56%.

But let’s get back to the local markets now and take stock of how the various ASX sectors handled today’s difficult trading conditions.

Winners and losers

Despite today’s pessimism, we still saw a few sectors make hay.

But first, it was gold shares that copped the worst of it. The All Ordinaries Gold Index (ASX: XGD) ended up crashing 3.08%.

Broader mining stocks had a rough one as well, with the S&P/ASX 200 Materials Index (ASX: XMJ) cratering 2.21%.

Continuing with the commodities theme, energy shares also had a shocker. The S&P/ASX 200 Energy Index (ASX: XEJ) tanked 1.62% this session.

Financial stocks had a day to forget as well, illustrated by the S&P/ASX 200 Financials Index (ASX: XFJ)’s 1.08% plunge.

Real estate investment trusts (REITs) fared a little better. The S&P/ASX 200 A-REIT Index (ASX: XPJ) still lost 0.59%, though.

Industrial shares were right behind that, with the S&P/ASX 200 Industrials Index (ASX: XNJ) sliding 0.43%.

Our last losers this Tuesday were utilities stocks. The S&P/ASX 200 Utilities Index (ASX: XUJ) ended up slipping down 0.12%.

Let’s turn to the green sectors now. Leading the winners were healthcare shares, as you can see from the S&P/ASX 200 Healthcare Index (ASX: XHJ)’s 1.5% surge.

Consumer staples stocks held their value, too. The S&P/ASX 200 Consumer Staples Index (ASX: XSJ) jumped 0.88% this session.

Its consumer discretionary counterpart was just behind that, with the S&P/ASX 200 Consumer Discretionary Index (ASX: XDJ) leaping 0.87%.

Communications stocks were spared as well. The S&P/ASX 200 Communication Services Index (ASX: XTJ) advanced 0.32%.

Finally, tech shares managed to stay on the right side of the line, evident by the S&P/ASX 200 Information Technology Index (ASX: XIJ)’s 0.29% bump.

Top 10 ASX 200 shares countdown

Healthcare stock 4DMedical Ltd (ASX: 4DX) was our chart-topper this Tuesday. 4DMedical shares roared 8.72% higher this session to close at $3.74 each.

This came despite no fresh news or announcements from the company today.

Here’s how the other top stocks landed their planes:

ASX-listed company	Share price	Price change
4DMedical Ltd (ASX: 4DX)	$3.74	8.72%
Telix Pharmaceuticals Ltd (ASX: TLX)	$17.75	8.63%
Life360 Inc (ASX: 360)	$20.52	5.02%
Perpetual Ltd (ASX: PPT)	$18.70	3.54%
News Corporation (ASX: NWS)	$47.21	3.19%
AUB Group Ltd (ASX: AUB)	$28.91	3.18%
New Hope Corporation Ltd (ASX: NHC)	$6.47	3.03%
ResMed Inc (ASX: RMD)	$31.37	2.85%
JB Hi-Fi Ltd (ASX: JBH)	$67.19	2.85%
Megaport Ltd (ASX: MP1)	$16.79	2.69%

Our top 10 shares countdown is a recurring end-of-day summary that shows which companies made big moves on the day. Check in at Fool.com.au after the weekday market closes to see which stocks make the countdown.

The post Here are the top 10 ASX 200 shares today appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: Domino’s Pizza, Telix Pharmaceuticals, Westfarmers shares
• ASX 200 drops again as selling continues
• $10,000 invested in Zip and New Hope shares 3 years ago is now worth…
• New Hope shares near 52-week high. Here’s what stood out in the result
• 3 ASX 200 shares tipped by experts to jump 30% to 62%

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, Megaport, ResMed, and Telix Pharmaceuticals. The Motley Fool Australia has positions in and has recommended Life360 and ResMed. The Motley Fool Australia has recommended Aub Group and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Commonwealth Bank of Australia (ASX: CBA) is a powerful ASX dividend share with an impressive market share and a proud record of paying pleasing passive income to shareholders.

However, CBA is not one of the businesses I’d buy for dividends, as impressive as the ASX bank share has been.

FY26 saw the business hike its annual dividend per share by 4% to $5.05. At the time of writing, that translates into a grossed-up dividend yield of 4.7%, including franking credits.

For me, there are other ASX dividend shares that offer a more compelling dividend yield and/or significantly more dividend growth potential. The following two stocks are much more appealing to me.

L1 Long Short Fund Ltd (ASX: LSF)

This business is a listed investment company (LIC), which means it invests in other shares/assets on behalf of shareholders. Having that diversification within a single investment is appealing compared to CBA, which is just one business and has a significant focus on providing home loans in Australia (an area of slow growth at best, right now).

L1 generally likes to look at industries and specific businesses that don’t get as much investor attention and don’t trade on high price/earnings (P/E) ratios. The investment team have delivered significant success in industries like materials, industrials and communication services.

Buying (and selling) materials shares at the right times can be very effective as investments because of how cyclical they can be.

At the end of August 2026, the ASX dividend share’s portfolio registered an average net return of 17.1% per year over the prior five years, which is strong enough to deliver both capital growth and good dividends.

In FY26, the LIC grew its annual payout by 14.5% – a much stronger growth rate than CBA.

I expect the next four quarterly dividends from L1 Long Short Fund will come to at least 16.2 cents per share, which would be a grossed-up dividend yield of 4.8%, including franking credits.

WCM Quality Global Growth Fund – Active ETF (ASX: WCMQ)

The other ASX dividend share I want to highlight is this exchange-traded fund (ETF) offering from WCM.

WCM is a fund manager based in Laguna Beach, California. That’s a deliberate choice to be so far away from the noise of Wall Street in New York.

There are two key criteria for WCM to consider a company for this portfolio. It must have a growing competitive advantage (expanding economic moat) and a corporate culture that supports the expansion of the economic moat.

The fund manager believes that the direction of the economic moat is more important than the absolute width or size. Therefore, seeing a rising return on invested capital (ROIC) – one of the main ways it measures that improvement – is more important than a large but static or declining economic moat.

Additionally, WCM has team members solely dedicated to analysing the corporate culture of a business.

Since the WCMQ ETF’s inception in August 2018, its portfolio has returned an average of 14.9% (net), compared to a 12.8% return per year for the global share market.

The ASX dividend share aims to provide a minimum annualised cash dividend yield of 5%. That’s a stronger starting yield than CBA shares and I expect the distribution can grow at a faster pace over the long-term by focusing on high-quality shares.

The post Forget CBA shares! Buy these ASX dividend shares instead for passive income appeared first on The Motley Fool Australia.

More reading

• ASX 200 drops again as selling continues
• Down 12%: Are CBA shares a buy, sell or hold now?
• Westpac, ANZ, NAB or CBA shares? Which ASX bank stock should I buy for $5,000 a year in passive income?
• How much is needed in superannuation to target a $6,500 monthly passive income?
• Vanguard ETFs vs. Betashares ETFs: Who’s coming out on top?

Motley Fool contributor Tristan Harrison has positions in L1 Long Short Fund and Wcm Quality Global Growth Fund. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) has fallen further this week as investor sentiment continues to deteriorate.

Ongoing conflict between the US and Iran is driving fresh concerns about restricted oil supply and inflation, and the renewed fears about further interest rate hikes are spooking investors.

Let’s find out how the shift in sentiment is affecting major ASX 200 shares like Domino’s Pizza Enterprises Ltd (ASX: DMP), Telix Pharmaceuticals Ltd (ASX: TLX), and Wesfarmers Ltd (ASX: WES), and what brokers tip next.

Buy Telix Pharmaceuticals shares

Telix shares have rocketed over 10% higher in Tuesday afternoon trade to $17.99 apiece. Today’s increase means the shares are now up 58% year to date.

Today’s increase comes on the back of yesterday’s news that its brain cancer imaging drug, Pixclara, has received approval from the US FDA. This makes it the first FET-PET imaging drug cleared for use in glioma and expands Telix’s precision medicine portfolio.

Telix says Pixclara is already the subject of a Phase 3 trial for diagnosis in additional brain conditions, with potential expansion to brain metastases. 

The company said it plans to target market leadership in both imaging and treatment for several high-need cancers.

Telix’s broader pipeline includes late-stage assets in prostate, kidney, and glioblastoma cancers, with a focus on bringing further precision medicine products to both existing and new markets worldwide.

Investors were clearly thrilled with the news, and many are rushing to snap up the shares.

Analysts are very bullish on the outlook for the stock, too. Market Index data shows the majority of brokers have a buy rating on the shares, and even after today’s share price spike, the $24.68 average target price implies there is potential for about 37% upside ahead.

Hold Domino’s Pizza shares

Domino’s Pizza shares have climbed higher on Tuesday afternoon, up around 1% to $19.14 a piece at the time of writing. The shares are still down 12% year to date.

It’s been a volatile month for the pizza operator. Its share price fell around 6% after the food operator announced its FY26 results, including a 11.2% decrease in revenue, and a statutory NPAT loss of $134.2 million. It also announced $255.7 million in non-cash write-downs and impairments.

Domino’s underlying NPAT was up 4% for the 12-month period, and in line with guidance, but EBITDA fell 6.1%. The company also cut its total FY26 dividend by 25.3% to 57.5 cents.

Going forward, Domino’s said it is planning to return to profitable growth in FY27 after a period of resetting its store network and business model. 

But it looks like the experts are on the fence about whether this growth can come to fruition. Market Index data shows the majority of brokers have a hold rating on the ASX shares. The $20.10 average target price implies an upside of around 5% at the time of writing.

Sell Wesfarmers shares

Wesfarmers shares are in the red at the time of writing, down around 0.5% to $72.42 each. The shares have crashed by around 22% since late July and are now down 11% for the year to date.

The shares were pushed lower in August amid broad pressure on consumer and retail stocks, as well as concerns about inflation and interest rate increases.

The sell-off also picked up pace after the conglomerate posted its FY26 results in late August.

The company reported a 3.4% increase in revenue to $47.3 million and a 7.3% increase in EBIT. But statutory NPAT fell 1.8% to $2.8 million, including significant items, or was up 8.3% excluding them. 

Going forward, Wesfarmers said it expects higher capital expenditure in FY27, of $1.3 billion to $1.5 billion. 

But investors were spooked, potentially because, although the result was robust, it raises questions about how the business can continue to grow in a weakening market.

Brokers are concerned, too. Market Index data shows the majority now have a strong sell rating on Wesfarmers shares. After the latest price crash, the $77 average target price implies around a 6% upside at the time of writing.

The post Buy, hold, sell: Domino’s Pizza, Telix Pharmaceuticals, Westfarmers shares appeared first on The Motley Fool Australia.

More reading

• How much is needed in superannuation to target a $6,500 monthly passive income?
• Here are the top 10 ASX 200 shares today
• Why are Telix Pharmaceuticals shares charging higher today?
• Telix Pharmaceuticals shares: FDA approves Pixclara brain cancer drug
• By September 2027, Wesfarmers shares could turn $10,000 into…

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Domino’s Pizza Enterprises, Telix Pharmaceuticals, and Wesfarmers. The Motley Fool Australia has recommended Domino’s Pizza Enterprises, Telix Pharmaceuticals, and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.